不同药物联合对男性高血压患者勃起功能的影响
Effect of Combined Antihypertensive Therapy on the Erectile Function in Male Hypertensives
查看参考文献16篇
文摘
|
目的探讨不同联合降压方案对高血压男性患者勃起功能的影响.方法采用前瞻性随机,平行,对照,固定治疗方案将148名≤60岁男性高血压患者随机分为3组:A组[非洛地平5 mg/d+厄贝沙坦150 mg/d(n=49)],B组[非洛地平5 mg/d+琥珀酸美托洛尔47.5 mg/d(n=46)],C组[非洛地平5 mg/d+氢氯噻嗪12.5 mg/d(n=53)].治疗4周若血压≥140/90 mm Hg,非洛地平剂量加倍.随访6月.采用国际男性性功能判断指标(IIEF-5)分别于治疗前,后对IIEF-5和血清睾酮,性激素结合球蛋白(SHBG)进行评定.结果治疗后3组降压达标率,有效率组间比较均无统计学差异(均P>0.05).治疗前,后勃起功能障碍(ED)的总发生率分别为34.46%,35.81%,差异无统计学意义(P>0.05).3组治疗前后轻,中,重度ED的发生率之间亦无统计学差异.3组治疗前后中,重度ED的IIEF-5评分比较无统计学差异,但A组可提高轻,中度ED患者的IIEF-5评分.3组血清睾酮和SHBG治疗前后比较无统计学差异.结论非洛地平缓释片联合厄贝沙坦片有利于男性高血压轻,中度ED患者性功能的改善 |
其他语种文摘
|
Objective This study was to assess the effect of different combination antihypertensive therapy on erectile dysfunction(ED) in male hypertensives. Methods A total of 148 male hypertensives aged ≤60 years were enrolled in this prospective randomized controled interventional study, and followed up for 6 months. Patients were divided into 3 groups including Felodipine(5 mg/d)+Irbesartan(150 mg/d)(A,n=49), Felodipine(5 mg/d)+Metoprolol(47.5 mg/d)(B,n=46) and Felodipine(5 mg/d)+Hydrochlorothiazide(12.5 mg/d)(C,n=53) respectively. Doses of Felodipine were doubled after 4 weeks if blood pressure was ≥140/90 mm Hg. Erectile function was assessed according to the 5-Item version of the international index of erectile dysfunction(IIEF-5) questionnaire. Blood samples were taken for assessing the testosterone(T) and the sex hormone binding globulin(SHBG). Results There were a significant blood pressure decrease in all 3 groups(P<0.01) and no difference(P>0.05) among these 3 groups. There was no statistically significant difference of total prevalence of ED between before and after treatment, with prevalence rate of 34.46% and 35.81%.An improvement of sexual function was noted in the patients with mild to moderate sexual dysfunction in group A. There was no significant difference of sexual function between group A and B. There were some changes of the testosterone and SHBG between groups before and after treatment in 6 months follow up(P>0.05). Conclusion Combination therapy is effective to lowing blood pressure of hypertensive. Combination of treatment of Felodipine +Irbesartan seems be better to prevent the ED in male hypertensives with mild to moderate sexual dysfuntion |
来源
|
中华高血压杂志(中英文)
,2010,18(4):365-369 【扩展库】
|
关键词
|
高血压
;
勃起功能
;
非洛地平
;
厄贝沙坦
;
琥珀酸美托洛尔
;
氢氯噻嗪
|
地址
|
1.
兰州大学第二医院心血管内科, 甘肃, 兰州, 730030
2.
69210部队医院内科, 新疆, 喀什, 844700
|
语种
|
中文 |
文献类型
|
研究性论文 |
ISSN
|
1673-7245 |
学科
|
临床医学 |
基金
|
甘肃省技术研究与开发专项计划
|
文献收藏号
|
CSCD:4008207
|
参考文献 共
16
共1页
|
1.
NIH Consensus Conference. Impotence. NIH consensus development panel on impotence.
JAMA,1993,270(1):83-90
|
CSCD被引
31
次
|
|
|
|
2.
Fecik SE. Drug-induced sexual dysfunction.
Med Update Psychiatr,1998,6(3):176-181
|
CSCD被引
1
次
|
|
|
|
3.
中国高血压防治指南修订委员会. 中国高血压防治指南(2005年修订版).
高血压杂志,2005,13(增刊):2-37
|
CSCD被引
119
次
|
|
|
|
4.
Feldman HA. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study.
Prev Med,2000,30(4):328-338
|
CSCD被引
22
次
|
|
|
|
5.
Keene LC. Drug-related erectile dysfunction.
Adverse Drug React Toxicol Rev,1999,18(1):5-24
|
CSCD被引
4
次
|
|
|
|
6.
Manolis A. Sexual dysfunction: the 'prima ballerina' of hypertension-related quality-of-life complications.
J Hypertens,2008,26(11):2074-2084
|
CSCD被引
5
次
|
|
|
|
7.
Buranakitjaroen P. Prevalence of erectile dysfunction among treated hypertensive males.
J Med Assoc Thai,2006,89(Suppl 5):S28-S36
|
CSCD被引
4
次
|
|
|
|
8.
Fogari R. Effect of antihypertensive agents on quality of life in the elderly.
Drugs Aging,2004,21(6):377-393
|
CSCD被引
3
次
|
|
|
|
9.
Doumas M. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects.
J Androl,2006,27(3):469-477
|
CSCD被引
15
次
|
|
|
|
10.
马嵘. 不同年龄男性血浆睾酮水平的研究.
中华老年医学杂志,2004,23(8):549-550
|
CSCD被引
11
次
|
|
|
|
11.
Cates JM. Characterization and developmental expression patterns of testicular androgen-binding protein in the Djungarian hamster (Phodopus sungorus).
J Reprod Fertil,1997,111(2):291-298
|
CSCD被引
1
次
|
|
|
|
12.
Janne M. Human sex hormonebinding globulin gene expression in transgenic mice.
Mol Endocrinol,1998,12(1):123-136
|
CSCD被引
2
次
|
|
|
|
13.
Rhoden EL. The relationship of serum testosterone to erectile function in normal aging men.
J Urol,2002,167(4):1745-1748
|
CSCD被引
3
次
|
|
|
|
14.
Guay A. The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction.
J Sex Med,2007,4(4 Pt 1):1046-1055
|
CSCD被引
9
次
|
|
|
|
15.
Araujo AB. Prevalence of symptomatic androgen deficiency in men.
J Clin Endocrinol Metab,2007,92(11):4241-4147
|
CSCD被引
25
次
|
|
|
|
16.
Baumhakel M. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome.
Int J Impot Res,2008,20(5):493-500
|
CSCD被引
9
次
|
|
|
|
|